Three-Dimensional Cell Adhesion Matrix

Tech ID: 19575 / UC Case 2009-700-0

Abstract

A novel cell adhesion matrix incorporating molecular recognition elements for tissue engineering.

Full Description

Researchers at the University of California, Davis have invented a series of novel, bioactive, purely synthetic and "made-to-order" cell adhesion matrices which incorporate molecular recognition elements such as cell surface integrin receptor ligands. These biodegradable and biocompatible nanofibrous matrices are advantageous for three-dimensional (3D) tissue culture and tissue engineering. They are comprised of high molecular weight polyvinyl alcohol (PVA) scaffolds functionalized with high-affinity cell adhesion ligands against naturally expressed or cell-transfected integrins, and cross-linked via cyclic complexation of boronic acid crosslinkers with polyhydroxyls on PVA. By using a number of biocompatible modified polymers, researchers can fine-tune the crosslink density and mechanical properties of the matrices. Cell incorporation is achieved by simultaneous encapsulation of cells in situ within the forming matrices, which occurs rapidly at room temperature and physiological pH. Alternatively, cells can be seeded and maintained in culture atop a pre-formed matrix. Extracellular matrices suitable for 3D culture of different cell types can be made to order by combinatorially incorporating a number of molecular recognition elements, such as ligands which target cell-expressed integrins, into the matrix. Finally, crosslinking of the bioactive PVA scaffolds is reversible on demand by the addition of a cis-diol competitor such as fructose, facilitating non-enzymatic degradation of the hydrogel matrix and rapid extraction of cells from 3D culture for other biological applications.

Applications

  • Stem cell maintenance, directed-differentiation, transplant and engraftment
  • Eliciting morphogenic patterns observed in commercially available laminin-rich chemically undefined extracellular matrices
  • Stem cell maintenance, directed-differentiation, transplant and engraftment
  • 3D cell culture
  • Culturing of cognate integrin-expressing tissue types including, but not limited to:
    • endothelial cells
    • embryonic stem cells
    • hematopoietic stem cells and mesenchymal stem cells
    • both non-malignant and malignant human mammary epithelial cells
    • human colon adenocarcinoma

Features/Benefits

  • Synthetic biomaterial scaffolds with defined bioactive molecular recognition elements
  • Fine-tunable mechanical properties
  • Purely synthetic and well-characterized
  • reproducible and localized investigation of cell response to biochemical cues

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 9,296,988 03/29/2016 2009-700
 

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Lam, Kit S.
  • Luo, Juntao
  • Onofiok, Ekema

Other Information

Categorized As